Correlation Between Yili Chuanning and Shanghai Rongtai

Can any of the company-specific risk be diversified away by investing in both Yili Chuanning and Shanghai Rongtai at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Yili Chuanning and Shanghai Rongtai into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Yili Chuanning Biotechnology and Shanghai Rongtai Health, you can compare the effects of market volatilities on Yili Chuanning and Shanghai Rongtai and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Yili Chuanning with a short position of Shanghai Rongtai. Check out your portfolio center. Please also check ongoing floating volatility patterns of Yili Chuanning and Shanghai Rongtai.

Diversification Opportunities for Yili Chuanning and Shanghai Rongtai

0.72

Correlation Coefficient

Yili Chuanning  Shanghai Rongtai

Poor diversification

The 3 months correlation between Yili and Shanghai is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Yili Chuanning Biotechnology and Shanghai Rongtai Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rongtai Health and Yili Chuanning is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Yili Chuanning Biotechnology are associated (or correlated) with Shanghai Rongtai. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rongtai Health has no effect on the direction of Yili Chuanning i.e., Yili Chuanning and Shanghai Rongtai go up and down completely randomly.

Pair Corralation between Yili Chuanning and Shanghai Rongtai

Assuming the 90 days trading horizon Yili Chuanning is expected to generate 7.46 times less return on investment than Shanghai Rongtai. But when comparing it to its historical volatility, Yili Chuanning Biotechnology is 1.16 times less risky than Shanghai Rongtai. It trades about 0.03 of its potential returns per unit of risk. Shanghai Rongtai Health is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  1,474  in Shanghai Rongtai Health on December 25, 2024 and sell it today you would earn a total of  476.00  from holding Shanghai Rongtai Health or generate 32.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Yili Chuanning Biotechnology  vs.  Shanghai Rongtai Health

Yili Chuanning Biote

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Yili Chuanning Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Yili Chuanning is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shanghai Rongtai Health

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Yili Chuanning and Shanghai Rongtai

The main advantage of trading using opposite Yili Chuanning and Shanghai Rongtai positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Yili Chuanning position performs unexpectedly, Shanghai Rongtai can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rongtai will offset losses from the drop in Shanghai Rongtai's long position.

The idea behind Yili Chuanning Biotechnology and Shanghai Rongtai Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.